Recommendations Changed for Cancer Drug Tamoxifen

A new recommendation by the U.S. Preventative Services Task Force endorses the cancer drug tamoxifen for cancer-free women who may be at high risk for developing breast cancer. This new statement, reported on April 15 by The New York Times, comes within months of recommending women with breast cancer take tamoxifen for 10 years.